Socioeconomic determinants such as income, education, occupation and social support profoundly influence the course and severity of multiple sclerosis (MS). Individuals with higher socioeconomic ...

Understanding the associations and potential drivers of long-term disability in Multiple Sclerosis (MS) is of clinical and prognostic value. Previous data have suggested a link between depression and ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

Among multiple sclerosis (MS) patients, those with a high relative abundance of Fusobacterium nucleatum together with other periodontal bacteria were more likely to have moderate to severe disability ...

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis ...

High fish consumption was linked with slower disability progression in MS. Benefits were seen for both lean and oily fish consumption. Protective effects were strongest with consistent fish ...

About 2.8 million people globally live with multiple sclerosis (MS). Two-thirds of people with MS move to a worsened state of the disease called secondary progressive MS. Researchers from the ...